Detalhe da pesquisa
1.
Risk factors for fibrosis progression in non-alcoholic steatohepatitis: Analysis of the European cohort in the real-world GAIN study.
Gastroenterol Hepatol
; 2023 Oct 27.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37890583
2.
Examining patient and professional perspectives in the UK for gene therapy in haemophilia.
Haemophilia
; 28(4): 588-609, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438818
3.
Health state utilities for beta-thalassemia: a time trade-off study.
Eur J Health Econ
; 24(1): 27-38, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35347553
4.
The Cost of Von Willebrand Disease in Europe: The CVESS Study.
Clin Appl Thromb Hemost
; 28: 10760296221120583, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979588
5.
Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States.
Medicine (Baltimore)
; 100(50): e28165, 2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918671
6.
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN study.
JHEP Rep
; 2(5): 100142, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32775976